RxNews®

August 11, 2026 - American Regent announced a voluntary, consumer level recall of three lots of epinephrine injection 30 mg/mL (1 mg/mL), 30 mL vial due to leaking and cracked vials, resulting in a loss of container closure integrity and a potential loss of sterility assurance.

August 13, 2026 - Salix/Bausch Health announced a business decision to discontinue Plenvu (polyethylene glycol 3350/potassium chloride/sodium chloride/sodium sulfate/ascorbic acid/sodium ascorbate) oral powder for solution. Plenvu is not being discontinued for reasons of safety or effectiveness.

August 13, 2026 - The FDA announced the approval of Bristol Myers Squibb’s Zenbexus (iberdomide), in combination with daratumumab and hyaluronidase-fihj and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least 1 prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.